Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 321

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis

Open access
Sharp, Trevor, Bramwell, Steven R., Grahame‐Smith, David G.·1989·British Journal of Pharmacology

Abstract

An intracerebral perfusion method, brain microdialysis, was used to assess changes of 5‐hydroxytryptamine (5‐HT) release in the ventral hippocampus of the chloral hydrate‐anaesthetized rat in response to systemic administration of a variety of 5‐HT 1 receptor agonists. A stable output of reliably detectable endogenous 5‐HT was measured in dialysates collected from ventral hippocampus with the 5‐HT reuptake inhibitor, citalopram, present in the perfusion medium. Under these conditions the putative 5‐HT 1A agonist 8‐hydroxy‐2‐(di‐n‐propylamino)tetralin (8‐OH‐DPAT) caused a dose‐dependent (5–250 μg kg−1, s.c.) reduction of 5‐HT in hippocampal dialysates. Similarly, the putative 5‐HT 1A agonists gepirone (5 mg kg−1, s.c.), ipsapirone (5 mg kg−1, s.c.) and buspirone (5 mg kg−1, s.c.) markedly reduced levels of 5‐HT in hippocampal perfusates whereas their common metabolite 1‐(2‐pyrimidinyl) piperazine (5 mg kg−1, s.c.), which does not bind to central 5‐HT 1A recognition sites, had no effect. 5‐Methoxy‐3‐(1,2,3,6‐tetrahydro‐4‐pyridinyl)‐lH‐indole (RU 24969), a drug with reported high affinity for brain 5‐HT 1B binding sites, also produced a dose‐dependent (0.25–5 mg kg−1, s.c.) decrease of hippocampal 5‐HT output. These data are direct biochemical evidence that systemically administered putative 5‐HT 1A and 5‐HT 1B agonists markedly inhibit 5‐HT release in rat ventral hippocampus in vivo.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.1989.tb11815.x

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 321

Metadata

Authors
Sharp, T., Bramwell, S. R., & Grahame‐Smith, D. G.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1989-02
Volume
96
Issue
2
Pages
283-290
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1999490123
Cited by
321
References
45
FWCI
9.29
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. https://app.cochat.ai/papers/10.1111/j.1476-5381.1989.tb11815.x
The paper
Sharp, T., Bramwell, S. R., & Grahame‐Smith, D. G. (1989). 5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1989.tb11815.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.